Frequency of Prescription Claims for Drugs that May Interact with Janus kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US
media
posted on 2021-01-06, 16:24 authored by Alison Walton, Jim Paik, Amanda Quebe, Carol L. Kannowski, Casey Choong, Seth Anderson, Justin K. Owensby<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
